123I-FP-CIT SPECT has been successfully used to detect the loss of dopaminergic nigrostriatal neurons in Parkinson's disease at an early stage. In this study we evaluated the capacity of 123I-FP-CIT SPECT to assess bilateral dopamine transporter (DAT) loss in de-novo hemi-Parkinson's disease (PD) patients with one-sided clinical symptoms.
Filippi, L., Manni, C., Pierantozzi, M., Brusa, L., Danieli, R., Stanzione, P., et al. (2005). 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms. NUCLEAR MEDICINE COMMUNICATIONS, 26(5), 421-426.
123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms
PIERANTOZZI, MARIANGELA;STANZIONE, PAOLO;SCHILLACI, ORAZIO
2005-05-01
Abstract
123I-FP-CIT SPECT has been successfully used to detect the loss of dopaminergic nigrostriatal neurons in Parkinson's disease at an early stage. In this study we evaluated the capacity of 123I-FP-CIT SPECT to assess bilateral dopamine transporter (DAT) loss in de-novo hemi-Parkinson's disease (PD) patients with one-sided clinical symptoms.| File | Dimensione | Formato | |
|---|---|---|---|
|
NuclMedCom 2005 LD.pdf
solo utenti autorizzati
Licenza:
Non specificato
Dimensione
180.5 kB
Formato
Adobe PDF
|
180.5 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
